- Home
- IFS vs IBRX Comparison
IFS vs IBRX Comparison
Compare IFS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IFS | IBRX |
|---|---|---|
| Founded | 1897 | 2014 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 7.2B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IFS | IBRX |
|---|---|---|
| Price | $60.73 | $8.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $48.00 | $12.57 |
| AVG Volume (30 Days) | 262.5K | ★ 12.0M |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | N/A | ★ 38.71 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $113,288,000.00 |
| Revenue This Year | N/A | $88.59 |
| Revenue Next Year | $7.38 | $131.15 |
| P/E Ratio | $9.61 | ★ N/A |
| Revenue Growth | N/A | ★ 668.31 |
| 52 Week Low | $35.45 | $1.95 |
| 52 Week High | $59.39 | $12.43 |
Technical Indicators
Market Signals| Indicator | IFS | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.76 | 50.67 |
| Support Level | $43.37 | $6.69 |
| Resistance Level | N/A | $8.54 |
| Average True Range (ATR) | 1.75 | 0.67 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 95.41 | 45.31 |
Price Performance
Historical ComparisonAbout IFS Intercorp Financial Services Inc.
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services, and payments for retail customers and commercial clients in Peru. Its purpose is centered around building financial well-being together. The company has three operating business segments: Banking, mainly loans, credit facilities, deposits, and current accounts; Insurance provides life annuity products with single-premium payment and conventional life insurance products, as well as other retail insurance products; and Wealth management provides brokerage and investment management services. Inteligo serves mainly Peruvian citizens.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.